Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) was $290.70 for the day, up 2.60% from the previous closing price of $283.34. In other words, the price has increased by $2.60 from its previous closing price. On the day, 1.77 million shares were traded. ALNY stock price reached its highest trading level at $300.9 during the session, while it also had its lowest trading level at $287.77.
Ratios:
Our analysis of ALNY’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.71 and its Current Ratio is at 2.78. In the meantime, Its Debt-to-Equity ratio is 40.89 whereas as Long-Term Debt/Eq ratio is at 38.58.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on March 24, 2025, Upgraded its rating to Overweight and sets its target price to $328 from $280 previously.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 24 ’25 when PYOTT DAVID E I bought 7,440 shares for $299.00 per share.
Garg Pushkal bought 5,445 shares of ALNY for $1,633,500 on Mar 24 ’25. On Mar 21 ’25, another insider, Garg Pushkal, who serves as the Officer of the company, bought 4,321 shares for $285.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALNY now has a Market Capitalization of 37633150976 and an Enterprise Value of 37682110464. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.82 while its Price-to-Book (P/B) ratio in mrq is 560.25. Its current Enterprise Value per Revenue stands at 16.761 whereas that against EBITDA is -313.456.
Stock Price History:
The Beta on a monthly basis for ALNY is 0.28, which has changed by 0.91287756 over the last 52 weeks, in comparison to a change of 0.10838497 over the same period for the S&P500. Over the past 52 weeks, ALNY has reached a high of $304.39, while it has fallen to a 52-week low of $141.98. The 50-Day Moving Average of the stock is 12.83%, while the 200-Day Moving Average is calculated to be 14.83%.
Shares Statistics:
ALNY traded an average of 719.47K shares per day over the past three months and 1032720 shares per day over the past ten days. A total of 129.29M shares are outstanding, with a floating share count of 124.34M. Insiders hold about 4.41% of the company’s shares, while institutions hold 95.03% stake in the company. Shares short for ALNY as of 1740700800 were 2493180 with a Short Ratio of 3.47, compared to 1738281600 on 2943280. Therefore, it implies a Short% of Shares Outstanding of 2493180 and a Short% of Float of 2.21.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
